MARATHON BANCORP INC (MBBC) Fundamental Analysis & Valuation

NASDAQ:MBBC • US5657592060

Current stock price

13.66 USD
-0.12 (-0.87%)
Last:

This MBBC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MBBC Profitability Analysis

1.1 Basic Checks

  • MBBC had negative earnings in the past year.
  • MBBC had a positive operating cash flow in the past year.
MBBC Yearly Net Income VS EBIT VS OCF VS FCFMBBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

  • MBBC has a worse Return On Assets (-0.05%) than 90.55% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.31%, MBBC is doing worse than 90.55% of the companies in the same industry.
Industry RankSector Rank
ROA -0.05%
ROE -0.31%
ROIC N/A
ROA(3y)0.41%
ROA(5y)N/A
ROE(3y)3.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBBC Yearly ROA, ROE, ROICMBBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 1 2 3 4 5

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MBBC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBBC Yearly Profit, Operating, Gross MarginsMBBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MBBC Health Analysis

2.1 Basic Checks

  • MBBC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MBBC has less shares outstanding than it did 1 year ago.
  • MBBC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBBC Yearly Shares OutstandingMBBC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500K 1M 1.5M
MBBC Yearly Total Debt VS Total AssetsMBBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • There is no outstanding debt for MBBC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC12.32%
MBBC Yearly LT Debt VS Equity VS FCFMBBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBBC Yearly Current Assets VS Current LiabilitesMBBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 100K 200K 300K 400K 500K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. MBBC Growth Analysis

3.1 Past

  • The earnings per share for MBBC have decreased strongly by -108.48% in the last year.
  • Looking at the last year, MBBC shows a very negative growth in Revenue. The Revenue has decreased by -17.94% in the last year.
  • Measured over the past years, MBBC shows a decrease in Revenue. The Revenue has been decreasing by -3.42% on average per year.
EPS 1Y (TTM)-108.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160.66%
Revenue 1Y (TTM)-17.94%
Revenue growth 3Y-3.42%
Revenue growth 5YN/A
Sales Q2Q%-9.95%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBBC Yearly Revenue VS EstimatesMBBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

Find the best growth stocksShow best growing peers

0

4. MBBC Valuation Analysis

4.1 Price/Earnings Ratio

  • MBBC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBBC Price Earnings VS Forward Price EarningsMBBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MBBC indicates a rather expensive valuation: MBBC more expensive than 83.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 113.35
EV/EBITDA N/A
MBBC Per share dataMBBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MBBC Dividend Analysis

5.1 Amount

  • No dividends for MBBC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MBBC Fundamentals: All Metrics, Ratios and Statistics

MARATHON BANCORP INC

NASDAQ:MBBC (3/19/2026, 8:13:25 PM)

13.66

-0.12 (-0.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners18.98%
Inst Owner Change11.38%
Ins Owners9.32%
Ins Owner Change5.33%
Market Cap40.16M
Revenue(TTM)6.39M
Net Income(TTM)-98.30K
AnalystsN/A
Price TargetN/A
Short Float %0.25%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.29
P/FCF 113.35
P/OCF 40.36
P/B 1.27
P/tB 1.27
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY0.88%
OCF(TTM)0.34
OCFY2.48%
SpS2.17
BVpS10.74
TBVpS10.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE -0.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 5.55%
ROA(3y)0.41%
ROA(5y)N/A
ROE(3y)3.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 237.23%
Cap/Sales 10.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC12.32%
ROIC/WACCN/A
Cap/Depr(3y)324.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)11.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.94%
Revenue growth 3Y-3.42%
Revenue growth 5YN/A
Sales Q2Q%-9.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-196.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.06%
OCF growth 3Y-26.09%
OCF growth 5YN/A

MARATHON BANCORP INC / MBBC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MARATHON BANCORP INC?

ChartMill assigns a fundamental rating of 1 / 10 to MBBC.


Can you provide the valuation status for MARATHON BANCORP INC?

ChartMill assigns a valuation rating of 0 / 10 to MARATHON BANCORP INC (MBBC). This can be considered as Overvalued.


How profitable is MARATHON BANCORP INC (MBBC) stock?

MARATHON BANCORP INC (MBBC) has a profitability rating of 0 / 10.